[Pharmacotherapy for neuropathic pain caused by injury to the afferent nerve fibers].
Frijns
P D
PD
D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D017277:Drug Approval; D000077206:Gabapentin; D006801:Humans; D009426:Netherlands; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology; D009475:Neurons, Afferent / Q000473:pathology*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D018712:Analgesics, Non-Narcotic; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin